Investing Profile

Frank Torti

Investor

Vant Chair at Roivant Sciences

United States
Photo of Frank Torti, Investor

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
New Enterprise Associates (NEA) Network
32 CONNECTIONS
cb
Investor
$10K - $50K
$25K
12
CompanyStageDateRound SizeTotal Raised
Annexon Biosciences
Series CJul 2020$100M
Series DJul 2020$100M
Series CDec 2018$75M
Series BJun 2016$44M
$319M
Xoc Pharmaceuticals
Series AFeb 2018$30M
$30M
OrphoMed
Series AMay 2017$39M
$39M
Galera Therapeutics
Series BFeb 2016$5M
Series BOct 2015$37M
Series AMar 2015$4.7M
Series AAug 2014$4.7M
$62.4M
Co-investors: James Barrett
CITIC Pharmaceutical
Series DDec 2009$1M
Series CApr 2008$22.1M
$23.1M
Partner New Enterprise Associates (NEA)2007 - 2018